Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
NPY-5 receptor antagonist-1
Cat. No.:
OB0425LY-208
Appearance:
Solid
Purity:
99.86%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
NPY-5 receptor antagonist-1 is a selective antagonist that targets neuropeptide Y (NPY) type 5 receptors with favorable biological activity.
Synonyms:
432506-24-6; N-(9-Ethyl-9H-carbazol-3-yl)-2-(4-(pyridin-2-yl)piperazin-1-yl)acetamide;
CAS No.:
432506-24-6
Compound CID:
4879597
Formula:
C25H27N5O
Formula Weight:
413.51
Specification
Target:
Neuropeptide Y receptor
Pathway:
GPCR/G protein; Neuronal signaling
Solubility:
DMSO
Storage:
Storage at -20°C.
Applications:
NPY-5 receptor antagonist-1 can be used to study obesity, metabolic syndrome and other diseases related to energy metabolism.
